Research summary, editorial or commentary, 2018

Lowering Fluoroscopy Pulse Rates To Reduce Radiation Dose During Cardiac Procedures

Crowhurst J, Whitby M. Journal of medical radiation sciences. 2018

Read the original paper

In plain language

This editorial argues that lowering fluoroscopy pulse rates in cath and electrophysiology (EP) labs reduces patient dose and, per one cited trial, operator dose by about 40%, while acceptable images can be kept by tuning image processing.

At a glance

Type of study
Editorial or commentary
Who was studied
Interventional cardiologists, Electrophysiologists, Mixed lab staff, Patients
Summary based on
the full text

What it found

  • Badawy et al. reported that lowering the fluoroscopy pulse rate to 3 PPS for coronary angiography substantially reduced dose-area product (DAP) and Ka,r without a significant increase in fluoroscopy time.

    Key figures: up to 58% DAP reduction

  • In a cited randomised trial of 363 patients (Abdelaal et al.), 7.5 PPS versus 15 PPS lowered DAP and operator dose during diagnostic angiograms.

    Key figures: DAP 26% lower; operator dose 40% relative reduction

  • The 3 PPS evidence came from a single operator, so multi-operator studies with complication data are still needed.

  • In electrophysiology procedures, a modern system with low pulse rates and low dose per pulse reduced DAP by over 90% versus an older generation system.

    Key figures: over 90% DAP reduction

  • The authors urge site- and operator-specific optimisation of X-ray systems rather than default settings.

Limits to keep in mind

Editorial summarising other studies rather than presenting new data; the main 3 PPS study was retrospective with a single operator and no complication data.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.